ALLR ALLARITY THERAPEUTICS INC Investments/Divestments 8-K Filing 2024 - Strategic Pivot Announcement Allarity Therapeutics announces a strategic pivot to advance its clinical-stage candidate stenoparib for ovarian cancer treatment.Get access to all SEC 8-K filings of the ALLARITY THERAPEUTICS INC